Clinical trial
Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?
NCT01730846 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?
- Lead sponsor
- Yale University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- November 30, 2016
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking